asco 2021 lung recap: surgical outcomes & checkmate 816: nivolumab in early stage nsclc
Published 2 years ago • 292 plays • Length 11:30Download video MP4
Download video MP3
Similar videos
-
8:13
checkmate 816: combining chemo and opdivo - asco lung review 2022
-
6:10
asco 2021 lung recap: circulatory tumor dna
-
3:25
checkmate 816: neoadjuvant nivolumab chemotherapy for nsclc - onctalk lung 2023
-
8:08
asco 2021 lung recap: mylung consortium: overall biomarker testing
-
8:13
asco 2021 lung recap: fda analysis of immunotherapy with or without chemo in adv nsclc and low pdl-1
-
14:00
asco 2021 lung recap: impower010: atezolizumab after chemo in non-small cell lung cancer
-
12:35
the checkmate 816 trial: the success of adjuvant nsclc therapies - lung cancer onctalk 2022
-
5:27
asco 2021 lung recap: lurbinectedin in small cell lung cancer and the failed atlantis trial
-
6:38
asco 2021 lung recap: poseidon trial: durvalumab /- tremelimumab vs. chemo alone
-
11:48
asco lung cancer roundtable - nsclc trial updates: checkmate 9la opdivo and yervoy with chemo vs
-
16:41
asco lung cancer roundtable - trial updates in nsclc - adaura trial and post surgery egfr mutation
-
6:17
asco 2021 lung recap: amivantamab and mobocertinib for egfr exon 20
-
6:00
perioperative keytruda for early stage nsclc-leading developments & current questions in lung cancer
-
8:35
asco lung cancer roundtable - nsclc - the cityscape trial: anti tigit & immune checkpoint inhibitor
-
5:26
asco 2021 lung recap: codebreak 100: sotorasib in kras g12c mutation
-
11:42
asco lung cancer roundtable - nsclc trial updates: checkmate 227 opdivo yervoy combination today
-
4:45
the skyscraper trial: treatments for extensive stage small cell lung cancer - asco lung review 2022
-
7:45
asco 2021 lung recap: carbo/pemetrexed/pembro and acquired resistance in egfrm or alk nsclc